Genpharmasec Profile
Key Indicators
- Authorised Capital ₹ 56.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 55.37 Cr
as on 16-11-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 23.35 Cr
as on 16-11-2024
- Revenue -6.56%
(FY 2023)
- Profit 637.41%
(FY 2023)
- Ebitda 149.34%
(FY 2023)
- Net Worth -0.26%
(FY 2023)
- Total Assets -8.20%
(FY 2023)
About Genpharmasec
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531592.
The Corporate was formerly known as Generic Pharmasec Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 56.00 Cr and a paid-up capital of Rs 55.37 Cr.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹23.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Genpharmasec Limited India are Sohan Chaturvedi as CFO and Hardik Makwana as Company Secretary. Sneha Sadhwani, Rajesh Sadhwani, Sachin Aphandkar, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24231MH1992PLC323914
- Company No.
323914
- Stock Symbol
BSE : 531592
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Nov 1992
- Date of AGM
23 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Genpharmasec?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sohan Chaturvedi | CFO | 01-Nov-2022 | Current |
| Hardik Makwana | Company Secretary | 08-Apr-2024 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sneha Sadhwani  | Director | 02-Jan-2019 | Current |
| Rajesh Sadhwani | Director | 02-Jan-2019 | Current |
Sachin Aphandkar  | Director | 01-Nov-2022 | Current |
| Mayur Bhatt | Director | 01-Nov-2022 | Current |
| Sohan Chaturvedi | Whole-Time Director | 16-May-2024 | Current |
| Siddhesh Shende | Director | 04-Jul-2022 | Current |
Financial Performance and Corporate Structure Insights of Genpharmasec.
Genpharmasec Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.56% decrease. The company also saw a substantial improvement in profitability, with a 637.41% increase in profit. The company's net worth dipped by a decrease of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genpharmasec?
In 2022, Genpharmasec had a promoter holding of 59.96% and a public holding of 40.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clinigenome India Private LimitedActive 10 months 21 daysSohan Chaturvedi and Siddhesh Shende are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 May 2023 | ₹3.00 Cr | Open |
International Asset Reconstruction Company Pvt. Ltd. Creation Date: 12 Feb 1996 | ₹8.50 Cr | Satisfied |
International Asset Reconstruction Company Pvt. Ltd. Creation Date: 12 Feb 1996 | ₹3.50 M | Satisfied |
How Many Employees Work at Genpharmasec?
Unlock and access historical data on people associated with Genpharmasec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genpharmasec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genpharmasec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
